Tugce Uskur

Dr. Tugce Uskur

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2025 in Cureus
Verified
Journal Article
Open access
PDF file
TUTugce Uskur
Tugce Uskur
BKBedriye Feyza Kurt
Bedriye Feyza Kurt
BJBedriye Feyza Kurt Jr.
Bedriye Feyza Kurt Jr.
Introduction: Gastrointestinal (GI) bleeding is a significant clinical presentation in elderly patients, where comorbidities, polypharmacy, and drug-drug interactions markedly increase the risk of bleeding. The aim of this study was to evaluate the types of medications prescribed during the six months prior to the patients' admission and the potential risks associated with drug interactions in patients aged 65 and older diagnosed with GI bleeding. Methods: This retrospective study included 49 patients aged 65 and older who were admitted to the emergency department of Kırklareli Training and Research Hospital with a diagnosis of GI bleeding between January 1 and December 31, 2022. Patient demographics, type of GI bleeding (upper or lower), duration of hospital stay, clinical outcomes, and medications prescribed during the six months prior to hospitalization were recorded. Statistical analyses were performed using GraphPad Prism 8.0. Continuous variables were reported as mean±standard deviation and categorical variables were analyzed using Fisher’s exact test and Chi-square test, with a significance level of p<0.05. Results: The study included 49 patients, comprising 25 (51.02%) males and 24 (49.98%) females, with a mean age of 78.4±7.6 years. Female patients had a significantly higher mean age than males (p=0.045). Upper GI bleeding (81.6%) was more prevalent than lower GI bleeding (18.4%), with no statistically significant gender difference (p=0.7252). The mortality rate was 10.2%, with all deceased patients being female and diagnosed with upper GI bleeding (p=0.0226). A total of 110 medications were prescribed during the six months prior to hospitalization. Drug interactions were identified in 28 patients, with 67.9% classified as moderate and 28.6% as major. NSAIDs, anticoagulants, and antidepressants were the most frequently involved drug groups, significantly heightening the risk of GI bleeding. Conclusion: Polypharmacy and drug-drug interactions are critical factors that contribute to the increased risk of GI bleeding in elderly patients. Comprehensive evaluation of medication regimens and strategies to mitigate polypharmacy are essential for improving patient safety and outcomes in this population.

21 July 2025 in Cureus
Verified
Journal Article
Open access
PDF file
GFGokhan Faikoglu
Gokhan Faikoglu
KSKübra Saygisever-Faikoglu
Kübra Saygisever-Faikoglu
HOHande Ozbasak
Hande Ozbasak
SUSedat Askin Ugur
Sedat Askin Ugur
TUTugce Uskur
Tugce Uskur
SOSibel Ozyazgan
Sibel Ozyazgan
Objective: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and the accumulation of amyloid-beta (Aβ) peptides. The neuroprotective protein sestrin-2 (SESN2) has been implicated in the cellular response to oxidative stress and autophagy, processes that are disrupted in AD. This study explores the effects of phosphodiesterase inhibitors (PDEIs) roflumilast (RF), rolipram (ROL), and tadalafil (TAD) on SESN2 expression and autophagy in Aβ25-35-treated hippocampal neuron (HT-22) cell cultures. Methods: The HT-22 cells were exposed to 5 μM Aβ25-35 for 32 hours to induce AD-like pathology. Concurrently, cells were treated with PDEIs (ROL: 10 μM, TAD: 1.53 nM, RF: 5 μM). The SESN2, autophagy-related proteins (ATG5, beclin-1 (BECN1), LC3II), adenosine monophosphate-activated protein kinase (AMPK), and mTOR expression levels were analyzed using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blot techniques. Results: The Aβ25-35 exposure significantly increased SESN2 expression and altered the levels of autophagy-related proteins, resulting in decreased active AMPK (phosphorylated (p)-AMPK) and increased active mTOR (phosphorylated (p)-mTOR). Treatment with PDEIs reduced the elevated SESN2 expression and modulated autophagy-related protein levels, enhancing ATG5, BECN1, and LC3II expression. The PDEIs also restored p-AMPK levels and reduced p-mTOR expression in Aβ25-35-treated cells. Conclusion: The PDEIs exhibit neuroprotective effects in an in vitro AD model by reducing SESN2 overexpression and modulating autophagy through the AMPK/mTOR pathway. These findings suggest that PDEIs could be potential therapeutic agents for AD, targeting SESN2 and autophagy pathways to mitigate neurodegenerative damage.

30 August 2024 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
TUTugce Uskur
Tugce Uskur
OGOya Güven
Oya Güven
MTMustafa Tat
Mustafa Tat
Introduction: Lithium is a key medication for treating various neuropsychiatric disorders, with a narrow therapeutic index and significant drug interactions. Monitoring lithium blood levels is crucial. This study aims to investigate the relationship between lithium blood levels and demographic characteristics such as age and gender, as well as possible drug interactions, in patients with a history of lithium use who applied to various services and outpatient clinics.Materials & methods: The files of 438 patients who were admitted to various services and outpatient clinics of Kırklareli Training and Research Hospital between January 1 and December 31, 2023, were retrospectively reviewed. Patients’ blood lithium levels, gender, age, service/outpatient clinic they admitted to, other medications used, urea, creatinine, and eGFR values were recorded.Results: When the demographic characteristics of 438 patients were examined, 62% were female (270), 38% were male (168), and the average age was 46.3 ± 14.8 years, showing a normal distribution. It was found that 192 patients (71 males, 121 females) had therapeutic lithium blood levels, while 244 patients (97 males, 147 females) had levels below 0.6 mmol/L. Two female patients had blood levels above the therapeutic range (1.23 and 1.43 mmol/L). Among the clinics and services, the four most frequented were the psychiatry clinic (314 patients), internal medicine clinic (36 patients), emergency service (27 patients), and medical oncology clinic (17 patients). Of the 314 patients admitted to the psychiatry clinic, 168 had therapeutic drug levels; only 7 of the 36 admitted to internal medicine had therapeutic levels; 12 of the 27 patients in the emergency service had therapeutic levels; and all 17 patients in medical oncology had levels below therapeutic limits.Discussion: The data emphasize the importance of regular blood level monitoring to ensure lithium treatment’s efficacy and patient safety. It is noteworthy that most patients in the psychiatry clinic had therapeutic drug levels, while those in other clinics had lower levels.Conclusion: In conclusion, this study highlights the importance of regular blood level monitoring to ensure the efficacy and safety of lithium treatment.

31 August 2025 in Eurasian Journal of Toxicology
Verified
Journal Article
Closed access
TUTugce Uskur
Tugce Uskur
OGOya Güven
Oya Güven
Introduction Therapeutic Drug Monitoring (TDM) is the measurement of drug concentrations in blood and other body fluids, primarily performed to ensure appropriate treatment with drugs that have a narrow therapeutic range. Traditionally, TDM has been used to minimize drug toxicity. In addition, increasing interest in personalized pharmacotherapy in modern medicine has led to a broader application of TDM [1]. Situated at the intersection of clinical pharmacology, toxicology, and emergency medicine, TDM holds critical importance in patients presenting to the emergency department with symptoms such as altered mental status, cardiac arrhythmias, and seizures. Which drugs require TDM? TDM is routinely applied for drugs with a narrow therapeutic index, including antiepileptics, antidepressants, antineoplastics, antibiotics, cardioactive agents, and immunosuppressants [2]. While this approach plays an important role in disease management across various clinical settings, it is particularly vital in the diagnostic and therapeutic processes within emergency departments. Epileptic seizures and drug level monitoring in the emergency setting The number of patients presenting to the emergency department due to epileptic seizures is significant. Kamppi et al. reported that 3.3% of emergency visits between 2015 and 2018 were related to epileptic seizures and highlighted a substantial patient population within neurological emergency services [3]. In certain cases, rapid clinical decision-making is essential, requiring prompt treatment guided by rapid diagnostic tests. For this purpose, serum level measurements of older generation antiepileptic drugs—such as phenytoin, carbamazepine, and valproic acid—are commonly employed. However, newer generation antiepileptics, including lamotrigine, levetiracetam, and topiramate, exhibit more predictable pharmacokinetic properties, thus reducing the routine need for TDM [4]. Possibly for this reason, serum level monitoring for newer antiepileptic drugs is not available in every healthcare institution. Nevertheless, in special circumstances such as drug interactions, patient non-adherence, pregnancy, or impaired renal function, measuring drug concentrations of these agents may still be beneficial. Increasing the availability of such tests in healthcare settings should be a priority in the near future. Conclusion TDM remains a valuable approach, especially for optimizing therapy with drugs that have a narrow therapeutic window, and its use is expanding in the field of personalized pharmacotherapy. In emergency visits—particularly those due to epileptic seizures—monitoring of serum drug levels is crucial and is still more commonly performed for older generation antiepileptics. The accessibility of TDM for newer antiepileptic agents, as a key tool in individualized treatment strategies, deserves increased attention.

29 July 2025 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Open access
TUTugce Uskur
Tugce Uskur
FTFatma Ünlü Taşdemir
Fatma Ünlü Taşdemir
MÖMehmet Aykut Öztürk
Mehmet Aykut Öztürk
HSHaktan Sönmez
Haktan Sönmez
ZSZeynep Gizem Todurga Seven
Zeynep Gizem Todurga Seven
AAAhmet Gokhan Akkan
Ahmet Gokhan Akkan
Background: This study aims to investigate the effects of vitamin B12 on morphine-induced conditioned place preference (CPP), a model commonly used to assess the rewarding effects of drugs. Morphine is a potent analgesic widely used for moderate to severe pain, but it also poses a significant risk of addiction. Previous studies suggest that cyanocobalamin (vitamin B12) may enhance the analgesic effects of morphine and reduce tolerance, but its impact on morphine addiction remains unclear. Methods: The experiment followed phases of habituation, pre-conditioning, conditioning, and post conditioning. Adult male Wistar albino rats (250-300 g) were randomly divided into 3 groups (n=8 per group): control (saline), morphine (10 mg/kg), and a combination group of vitamin B12 (2 mg/kg) with morphine. The effects of saline, morphine, and the morphine-vitamin B12 combination on CPP were assessed. All drugs and saline were administered intraperitoneally (ip). Results: Morphine (10 mg/kg) significantly induced CPP compared to the saline group (P < .0001). Vitamin B12 (2 mg/kg) did not produce a statistically significant difference in morphine-induced CPP compared to the control group. Conclusion: Morphine induces a significant place preference, and vitamin B12 did not produce a statistically significant difference in reducing this effect. Further research with different doses of vitamin B12 is necessary to fully investigate these effects.

16 September 2025 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
TUTugce Uskur
Tugce Uskur
OGOya Güven
Oya Güven
Aims: Epilepsy is a chronic neurological disorder affecting 1-3% of the global population, characterized by recurrent seizures. Monitoring blood levels of valproic acid and carbamazepine, two commonly used antiepileptic drugs, is essential for effective seizure control. This study aims to analyze the serum concentrations, demographic characteristics and concomitant drug use of patients treated with valproic acid or carbamazepine. Methods: This retrospective study was conducted at Kırklareli Training and Research Hospital, analyzing the medical records of epilepsy patients treated with valproic acid or carbamazepine. Medical records of 440 epilepsy patients were retrospectively analyzed. Demographic data, concurrent medication use and blood drug levels were recorded, and rates of achieving therapeutic levels were compared. Results: Of the 440 patients, 378 were treated with valproic acid, and 62 with carbamazepine. In the valproic acid group, 62.2% reached therapeutic levels, with an average concentration of 68.15 µg/ml. In the carbamazepine group, only 27.4% reached therapeutic levels, with an average of 10.07 µg/ml. A statistically significant difference was found between the two groups. A significant association was found between drug interaction counts and non-therapeutic levels in the carbamazepine group (p